ArticleCureus2024
Diagnostic Challenges of Early T-cell Precursor Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is an uncommon subtype of T-cell acute lymphoblastic leukemia (T-ALL), constituting approximately 10-13% of T-ALL cases in childhood and 5-10% in adults. A 55-year-old female patient presented with no significant medical history and was hospitalized in the internal medicine department due to anemia and deterioration of her overall health. The clinical examination did not reveal any tumor syndrome. A complete blood count was performed showing normocytic normochromic anemia with leukocytosis. The myelogram revealed bone marrow invasion by blasts of 80%. Immunophenotyping revealed the presence of a blast population of T lymphoid nature estimated at 74% of the marrow elements with a particular immunophenotype. Thus, the diagnosis of ETP-ALL was retained. A karyotype was carried out showing the presence of a hypotetraploid clone with clonal anomalies in number and structure. The patient was put on hyper-CVAD protocol (cyclophosphamide, doxorubicine, vincristine, dexamethasone). A myelogram at the end of induction revealed the presence of 45% blasts. The categorization of ETP-ALL as a distinct entity in the WHO classification arises from its distinguishable phenotypic and genetic characteristics. However, the diagnosis and management of ETP-ALL always constitutes a challenge for the biologist and clinician. Therefore, it is essential to conduct more extensive studies for a better comprehension of the clinical and biological features of ETP-ALL, specifically focusing on its genetic nuances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.